Broadcast 2 FAQ’s

The surveillance of complete responders is involved and costly and is the biggest barrier to centres offering it routinely to patients as a treatment option. Does Gina have any advice on approaching this issue? Should it remain ‘experimental’ and only offered if part of a carefully monitored programme, or can the individual clinician try to just look after a complete response patient with the standard service and system around them? Thanks

This topic generates much discussion in our MDT and your thoughts / comments would be welcomed. What is the role of adjuvant chemotherapy in (fit) patients with high risk rectal cancer who have undergone neo-adjuvant long-course chemo-radiotherapy followed by surgery and the pathological stage is now favourable and does not meet criteria for consideration of adjuvant chemotherapy (however there remains concerns regarding adverse initial radiological stage [ie T4N1/2V1])? Many thanks.

Question to Mr Wynn, I know post resection MR rectum won’t be as good as Pre resection MR, but could the clips be removed with a biopsy forceps after few days, before the Pt had MR rectum? Just a thought. Many thanks

Is there still a role for ERUS in rectal large polyps? Or should we just move definitively towards assessment-staging MRI even for large polyps in the rectum?

Subscribe for updates on our courses
Subscribe to receive updates on the latest courses and online educational series available at the ICENI Centre
Remind Me Later
Thanks for signing up. You must confirm your email address before we can send you. Please check your email and follow the instructions.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.
×
×
WordPress Popup Plugin